Scott Salka
Chief Executive Officer
Healthcare
Aspyrian Therapeutics
Canada
Biography
Mr. Michael Scott Salka is a Consultant of AmpliPhi Biosciences Corporation since May 31, 2017. Mr. Salka serves as the Chief Executive Officer of Aspyrian, CendR and Vesper Biologics, all biotechnology companies. He served as a Director of Ambit Biosciences Corporation. He served as a Director of Sorrento Therapeutics, Inc. from February 23, 2012 to March 7, 2014 and served as its Member of Scientific Advisory Board. Mr. Salka received his B.S. in Finance from San Diego State University and his M.B.A. from the Carnegie Mellon University.
Research Interest
Health care
